Traws Pharma, Inc. Warrants and Rights Outstanding
Traws Pharma, Inc. (TRAW) had Warrants and Rights Outstanding of $44.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-14
- 2026-06-30: Warrants and Rights Outstanding $44.00K.
- 2026-03-31: Warrants and Rights Outstanding $259.00K.
- 2025-12-31: Warrants and Rights Outstanding $100.00K.
- 2025-09-30: Warrants and Rights Outstanding $11.00K.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2026-06-30 | $44.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $259.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $100.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $8.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $154.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $42.49M 10-K · filed 2026-04-15 | |
| 2021-06-30 | $530.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $636.00K 10-Q · filed 2022-05-13 | $957.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $321.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $176.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $232.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $176.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $113.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $96.00K 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $176.00K 10-K · filed 2020-03-27 | |
| 2017-12-31 | $1.77M 10-K · filed 2018-03-16 | |
| 2017-09-30 | $1.69M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.48M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |